Strain Information | |
---|---|
Image | |
BRC No. | RBRC04846 |
Type | Transgene |
Species | Mus musculus |
Strain name | B6.Cg-Tg(CAG-St6gal1)3 |
Former Common name | B6-St6gal1 Tg#3 |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | Developed by Yasuhiro Hashimoto, Fukushima Medical University in 2006. |
Strain description | |
Colony maintenance | Carrier x Noncarrier [C57BL/6] |
References | Immune regulation by the ST6Gal sialyltransferase. Hennet T, Chui D, Paulson J C, Marth J D Proc. Natl. Acad. Sci. USA, 95, 4504-4509 (1998). 9539767Alzheimer's beta-secretase, beta-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. Kitazume S, Tachida Y, Oka R, Shirotani K, Saido T C, Hashimoto Y Proc. Natl. Acad. Sci. USA, 98, 13554-13559 (2001). 11698669 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
FLAG | FLAG tag (synthetic) | UN | FLAG | ||||
St6gal1 | beta galactoside alpha 2,6 sialyltransferase 1 (rat) | UN | St6gal1 | CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | rat ST6GalI, synthetic FLAG epitope tag sequence, CAG promoter (CMV-IE enhancer, chicken beta-actin promoter, rabbit beta-globin genomic DNA) |
Research application | Cancer Research Immunology and Inflammation Research Virology Research |
Specific Term and Conditions | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from use of the BIOLOGICAL RESOURCE. For period of two (2) years after deposition by the DEPOSITOR to the REKEN BRC, the RESIPIENT agrees to include the DEPOSITOR/DEVELOPER (Yashuhiro Hashimoto, Shinobu Kitazume, Satoshi Futakawa) as a co-authors. |
Depositor | Yasuhiro Hashimoto (Fukushima Medical University) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |